How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Buy
52
CFG Quote, Financials, Valuation and Earnings
Last price:
$35.79
Seasonality move
:
4.24%
Day range:
$33.95 - $35.30
52-week range:
$32.60 - $49.25
Dividend yield:
4.87%
P/E ratio:
10.95x
P/S ratio:
1.99x
P/B ratio:
0.66x
Volume:
5.9M
Avg. volume:
6.2M
1-year change:
1.47%
Market cap:
$15.1B
Revenue:
$7.8B
EPS (TTM):
$3.15
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6.9B | $6.6B | $8B | $8.2B | $7.8B | |
| Revenue Growth (YoY) | 6.38% | -3.74% | 20.67% | 2.53% | -5.23% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.3B | $2.3B | $2.8B | $3B | $3B | |
| Other Inc / (Exp) | $4M | $10M | $9M | $28M | $18M | |
| Operating Expenses | $2.3B | $2.3B | $2.8B | $2.4B | $2.8B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.3B | $3B | $2.7B | $2B | $1.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $241M | $658M | $582M | $422M | $379M | |
| Net Income to Company | $1.1B | $2.3B | $2.1B | $1.6B | $1.5B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.1B | $2.3B | $2.1B | $1.6B | $1.5B | |
| Basic EPS (Cont. Ops) | $2.22 | $5.18 | $4.12 | $3.14 | $3.05 | |
| Diluted EPS (Cont. Ops) | $2.22 | $5.16 | $4.10 | $3.13 | $3.03 | |
| Weighted Average Basic Share | $427.1M | $425.7M | $476M | $475.1M | $450.7M | |
| Weighted Average Diluted Share | $428.2M | $427.4M | $477.8M | $476.7M | $453.5M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.1B | $3.3B | $3.7B | $6B | $6.4B | |
| Revenue (Reported) | $6.9B | $6.6B | $8B | $8.2B | $7.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.1B | $3.3B | $3.7B | $6B | $6.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7B | $1.6B | $2.1B | $2B | $1.9B | |
| Revenue Growth (YoY) | 0.06% | -0.78% | 29.36% | -8.08% | -1.07% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $582M | $640M | $732M | $802M | $696M | |
| Other Inc / (Exp) | $3M | $4M | $5M | $5M | $7M | |
| Operating Expenses | $583M | $603M | $666M | $720M | $696M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $781M | $536M | $664M | $430M | $468M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $170M | $116M | $153M | $96M | $95M | |
| Net Income to Company | $611M | $420M | $511M | $334M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $611M | $420M | $511M | $334M | $373M | |
| Basic EPS (Cont. Ops) | $1.38 | $0.94 | $1.00 | $0.66 | $0.78 | |
| Diluted EPS (Cont. Ops) | $1.37 | $0.93 | $1.00 | $0.65 | $0.77 | |
| Weighted Average Basic Share | $426M | $422.4M | $485.4M | $461.4M | $438.3M | |
| Weighted Average Diluted Share | $427.9M | $424.7M | $487.7M | $463.8M | $442.2M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $880M | $602M | $1.4B | $1.6B | $1.4B | |
| Revenue (Reported) | $1.7B | $1.6B | $2.1B | $2B | $1.9B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $880M | $602M | $1.4B | $1.6B | $1.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $6.9B | $6.6B | $8.5B | $8.1B | $7.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.3B | $2.4B | $2.9B | $3B | $2.9B | |
| Other Inc / (Exp) | $7M | $11M | $10M | $28M | $20M | |
| Operating Expenses | $2.3B | $2.3B | $2.7B | $2.5B | $2.8B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2B | $2.7B | $2.8B | $1.8B | $1.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $400M | $604M | $619M | $365M | $378M | |
| Net Income to Company | $1.6B | $2.1B | $2.2B | $1.4B | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $1.6B | $2.1B | $2.2B | $1.4B | $1.5B | |
| Basic EPS (Cont. Ops) | $3.58 | $4.74 | $4.17 | $2.78 | $3.17 | |
| Diluted EPS (Cont. Ops) | $3.57 | $4.72 | $4.15 | $2.76 | $3.15 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.6B | $3B | $4.5B | $6.2B | $6.3B | |
| Revenue (Reported) | $6.9B | $6.6B | $8.5B | $8.1B | $7.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.6B | $3B | $4.5B | $6.2B | $6.3B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.7B | $1.6B | $2.1B | $2B | $1.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $582M | $640M | $732M | $802M | $696M | |
| Other Inc / (Exp) | $3M | $4M | $5M | $5M | $7M | |
| Operating Expenses | $583M | $603M | $666M | $720M | $696M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $781M | $536M | $664M | $430M | $468M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $170M | $116M | $153M | $96M | $95M | |
| Net Income to Company | $611M | $420M | $511M | $334M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $611M | $420M | $511M | $334M | $373M | |
| Basic EPS (Cont. Ops) | $1.38 | $0.94 | $1.00 | $0.66 | $0.78 | |
| Diluted EPS (Cont. Ops) | $1.37 | $0.93 | $1.00 | $0.65 | $0.77 | |
| Weighted Average Basic Share | $426M | $422.4M | $485.4M | $461.4M | $438.3M | |
| Weighted Average Diluted Share | $427.9M | $424.7M | $487.7M | $463.8M | $442.2M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $880M | $602M | $1.4B | $1.6B | $1.4B | |
| Revenue (Reported) | $1.7B | $1.6B | $2.1B | $2B | $1.9B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $880M | $602M | $1.4B | $1.6B | $1.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $13B | $9.5B | $10.9B | $12B | $11.2B | |
| Short Term Investments | $22.4B | $25.4B | $23.7B | $29.7B | $32.6B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $39.3B | $37.7B | $36.9B | $43.3B | $45.3B | |
| Property Plant And Equipment | $759M | $768M | $844M | $895M | $875M | |
| Long-Term Investments | $25.5B | $27.6B | $33.5B | $38.6B | $41.1B | |
| Goodwill | $7.1B | $7.1B | $8.2B | $8.2B | $8.2B | |
| Other Intangibles | -- | $64M | $197M | $157M | $146M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $183.3B | $188.4B | $226.7B | $222B | $217.5B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $12M | $73M | $3M | $505M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $243M | $74M | $3M | $505M | $2B | |
| Long-Term Debt | $8.3B | $6.9B | $15.9B | $13.5B | $10.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $160.7B | $165B | $203B | $197.6B | $193.3B | |
| Common Stock | $2B | $2B | $2B | $2B | $2.1B | |
| Other Common Equity Adj | -$60M | -$665M | -$4.6B | -$3.8B | -$3.6B | |
| Common Equity | $20.7B | $21.4B | $21.7B | $22.3B | $22.1B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $22.7B | $23.4B | $23.7B | $24.3B | $24.3B | |
| Total Liabilities and Equity | $183.3B | $188.4B | $226.7B | $222B | $217.5B | |
| Cash and Short Terms | $35.4B | $34.9B | $34.6B | $41.7B | $43.8B | |
| Total Debt | $8.4B | $7B | $15.9B | $14B | $12.4B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $15B | $10.6B | $8.3B | $12B | $12.2B | |
| Short Term Investments | $23.9B | $24.5B | $22.5B | $31.1B | $34.2B | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $41.9B | $38.2B | $32.8B | $43.6B | $47.2B | |
| Property Plant And Equipment | $743M | $793M | $866M | $872M | $855M | |
| Long-Term Investments | $26.8B | $26.4B | $32B | $40B | $42.7B | |
| Goodwill | $7.1B | $7.2B | $8.2B | $8.2B | $8.2B | |
| Other Intangibles | -- | -- | $185M | $148M | $137M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $187.2B | $192.1B | $222.3B | $220.4B | $220.1B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $70M | $25M | $1B | $9M | $47M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $70M | $25M | $1B | $1.3B | $47M | |
| Long-Term Debt | $8.3B | $5.9B | $18.9B | $12.6B | $12.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $164.6B | $170B | $198.1B | $196.7B | $195.3B | |
| Common Stock | $2B | $2B | $2B | $2B | $2.1B | |
| Other Common Equity Adj | -$411M | -$2.3B | -$3.9B | -$4.2B | -$2.9B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $22.7B | $22.1B | $24.2B | $23.8B | $24.9B | |
| Total Liabilities and Equity | $187.2B | $192.1B | $222.3B | $220.4B | $220.1B | |
| Cash and Short Terms | $38.9B | $35.1B | $30.8B | $43.1B | $46.4B | |
| Total Debt | $8.4B | $5.9B | $19.9B | $13.8B | $12.3B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.1B | $2.3B | $2.1B | $1.6B | $1.5B | |
| Depreciation & Amoritzation | $578M | $625M | $565M | $478M | $498M | |
| Stock-Based Compensation | $48M | $59M | $84M | $87M | $97M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $111M | $2.3B | $4.1B | $3B | $2B | |
| Capital Expenditures | $118M | $124M | $126M | $172M | $122M | |
| Cash Acquisitions | -$3M | -$165M | -$255M | -- | -- | |
| Cash From Investing | -$6.1B | -$10.5B | -$12.6B | $5.2B | $3B | |
| Dividends Paid (Ex Special Dividend) | -$770M | -$783M | -$892M | -$928M | -$903M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $8.3B | -- | $24.6B | $26B | $13.2B | |
| Long-Term Debt Repaid | -$14.1B | -$1.4B | -$19.7B | -$28.4B | -$14.3B | |
| Repurchase of Common Stock | -$270M | -$545M | -$153M | -$906M | -$1.4B | |
| Other Financing Activities | -$96M | -$23M | -$25M | $21M | $18M | |
| Cash From Financing | $15.4B | $4.6B | $9.9B | -$7.1B | -$6B | |
| Beginning Cash (CF) | $3.4B | $12.7B | $9.2B | $10.5B | $11.6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $9.3B | -$3.6B | $1.4B | $1.1B | -$1B | |
| Ending Cash (CF) | $12.7B | $9.2B | $10.5B | $11.6B | $10.6B | |
| Levered Free Cash Flow | -$7M | $2.2B | $4B | $2.8B | $1.9B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $456M | $530M | $653M | $189M | $401M | |
| Depreciation & Amoritzation | $159M | $172M | $117M | $126M | $124M | |
| Stock-Based Compensation | $14M | $12M | $16M | $14M | $21M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $866M | $1.1B | $1.4B | $670M | $483M | |
| Capital Expenditures | $118M | $65M | -$15M | $48M | $48M | |
| Cash Acquisitions | -- | -$151M | -$20M | -- | -- | |
| Cash From Investing | -$637M | -$7.5B | -$158M | $225M | $1.6B | |
| Dividends Paid (Ex Special Dividend) | -$193M | -$193M | -$233M | -$230M | -$226M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $13.1B | $4.8B | -- | |
| Long-Term Debt Repaid | -$803M | $4M | -$13.5B | -$8.7B | -$1.5B | |
| Repurchase of Common Stock | -- | -$200M | -$151M | -- | -$225M | |
| Other Financing Activities | -$2M | -$1M | -$1M | $47M | $17M | |
| Cash From Financing | $3.3B | $1.8B | $1.1B | -$4.7B | -$2.4B | |
| Beginning Cash (CF) | $9.2B | $13.7B | $8.2B | $15.4B | $10.9B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $3.5B | -$4.6B | $2.4B | -$3.8B | -$314M | |
| Ending Cash (CF) | $12.7B | $9.2B | $10.5B | $11.6B | $10.6B | |
| Levered Free Cash Flow | $748M | $1B | $1.5B | $622M | $435M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1.6B | $2.1B | $2.2B | $1.4B | -- | |
| Depreciation & Amoritzation | $526M | $540M | $616M | $462M | -- | |
| Stock-Based Compensation | $49M | $70M | $84M | $88M | $63M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $748M | $4.5B | $3.7B | $2.4B | -- | |
| Capital Expenditures | $112M | $165M | $127M | $130M | $112M | |
| Cash Acquisitions | -- | -$308M | -$112M | -- | -- | |
| Cash From Investing | $1.6B | -$13.3B | -$7.2B | $4.8B | -- | |
| Dividends Paid (Ex Special Dividend) | -$778M | -$782M | -$932M | -$918M | -$675M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $30.3B | $26B | -- | |
| Long-Term Debt Repaid | -$9.6B | -$2.4B | -$21.4B | -$31.1B | -- | |
| Repurchase of Common Stock | -$95M | -- | -$553M | -$806M | -- | |
| Other Financing Activities | -$104M | -$24M | -$26M | $33M | -- | |
| Cash From Financing | $8.3B | $4.1B | $1.6B | -$3.5B | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $10.6B | -$4.7B | -$2B | $3.6B | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $636M | $4.4B | $3.6B | $2.2B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $2.3B | $2.1B | $1.6B | $1.5B | -- | |
| Depreciation & Amoritzation | $625M | $565M | $478M | $498M | -- | |
| Stock-Based Compensation | $59M | $84M | $87M | $97M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.3B | $4.1B | $3B | $2B | -- | |
| Capital Expenditures | $124M | $126M | $172M | $122M | -- | |
| Cash Acquisitions | -$165M | -$255M | -- | -- | -- | |
| Cash From Investing | -$10.5B | -$12.6B | $5.2B | $3B | -- | |
| Dividends Paid (Ex Special Dividend) | -$783M | -$892M | -$928M | -$903M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $24.6B | $26B | $13.2B | -- | |
| Long-Term Debt Repaid | -$1.4B | -$19.7B | -$28.4B | -$14.3B | -- | |
| Repurchase of Common Stock | -$545M | -$153M | -$906M | -$1.4B | -- | |
| Other Financing Activities | -$23M | -$25M | $21M | $18M | -- | |
| Cash From Financing | $4.6B | $9.9B | -$7.1B | -$6B | -- | |
| Beginning Cash (CF) | $53.8B | $33.8B | $45.5B | $45.9B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$3.6B | $1.4B | $1.1B | -$1B | -- | |
| Ending Cash (CF) | $50.2B | $35.2B | $46.6B | $44.9B | -- | |
| Levered Free Cash Flow | $2.2B | $4B | $2.8B | $1.9B | -- | |
Get CFG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CFG
Sector
P/E ratio
10.95x
10.71x
PEG ratio
0.77x
0.37x
P/B ratio
0.66x
1.00x
Price / LTM sales
1.99x
2.36x
Growth Metrics
CFG
Sector
Revenue growth
-1.07%
6.77%
Earnings growth
18.46%
7.04%
Revenue (5-year growth)
3.73%
5.17%
Earnings forecast
$0.75
$0.57
Profitability
CFG
Sector
Profitability FY 2025
--
$155.9M
Return on invested capital
4.13%
5.51%
Return on assets
0.71%
1%
Return on equity
6.36%
9.5%
Earnings Date
Last Earnings Date
Apr
16
Next Earnings Date
Jul
17
Estimated Next Earnings Date
Jul
16
Balance Sheet
CFG
Sector
Total cash
$46.4B
$471.6M
Short term investments
$32.6B
$241.7M
Total assets
$217.5B
$4.2B
Long term debt
$12.3B
$333.7M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
58
AGX alert for Apr 22
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
